Obesity gets you into the hospital, but age is what kills you there.
Desde os primeiros meses da pandemia, um padrão emergiu nas enfermarias do mundo inteiro: a obesidade, segunda maior vulnerabilidade para a COVID-19 grave depois da idade avançada, multiplicava as probabilidades de hospitalização e cuidados intensivos. Investigadores de vários países foram reunindo evidências que confirmavam esta ligação, embora os dados portugueses introduzissem uma nuance importante — entre os já hospitalizados, é a idade, e não o peso, que determina quem sobrevive. A história desta relação é também a história de uma desigualdade: a obesidade não é apenas uma condição clínica, mas um espelho das fragilidades sociais que a pandemia veio amplificar.
- Uma meta-análise de 75 estudos com 399 mil doentes revelou que a obesidade aumenta em 113% o risco de hospitalização por COVID-19 — um número que transformou a forma como os clínicos olhavam para os seus doentes.
- Nas unidades de cuidados intensivos britânicas durante a primeira vaga, 70% dos internados eram obesos ou tinham excesso de peso, com o impacto a cair de forma desproporcional sobre populações pobres e minorias étnicas.
- Investigadores portugueses encontraram uma distinção crucial: a obesidade aumenta a probabilidade de chegar aos cuidados intensivos, mas não eleva o risco de morte entre os já hospitalizados — a idade continua a ser o fator dominante de mortalidade.
- Os mecanismos biológicos começam a ser compreendidos — inflamação crónica, coagulação facilitada e maior concentração de recetores ACE2 criam um terreno fértil para a progressão grave da doença.
- Portugal optou por não incluir a obesidade nas primeiras fases de vacinação prioritária, pesando a dificuldade logística de verificação e o facto de a idade permanecer o preditor mais robusto de morte.
Na primavera de 2020, as enfermarias de todo o mundo começaram a revelar um padrão consistente: doentes com obesidade a ocupar camas em proporções que não podiam ser ignoradas. A pergunta tornou-se inevitável — seria a obesidade, por si só, um fator de risco para doença grave?
Uma meta-análise publicada em agosto de 2020, abrangendo 75 estudos e quase 400 mil doentes, respondeu com números expressivos: as pessoas com obesidade tinham 46% mais risco de infeção, 113% mais probabilidade de hospitalização e 74% mais risco de admissão em cuidados intensivos. Depois da idade avançada, a obesidade surgia como a vulnerabilidade mais significativa para doença grave.
Os investigadores portugueses, porém, trouxeram uma nuance. Vasco Ricoca Peixoto, da Escola Nacional de Saúde Pública em Lisboa, analisou os registos de 16 mil doentes hospitalizados. A conclusão: a obesidade aumentava a probabilidade de cuidados intensivos, mas não o risco de morte. A idade mantinha-se como preditor esmagador — aos 60 anos, o risco de morrer triplicava; aos 80, era sete vezes superior.
A biologia por detrás desta relação vai-se tornando mais clara. O tecido adiposo infiltra órgãos produtores de células imunitárias, enfraquecendo as defesas. Liberta também citocinas que alimentam uma inflamação crónica capaz de desencadear a chamada tempestade de citocinas. A coagulação facilitada e a maior concentração de recetores ACE2 completam um quadro de vulnerabilidade acrescida.
Os dados britânicos sublinharam a dimensão social da crise: o peso do internamento em cuidados intensivos caiu sobretudo sobre pessoas entre os 55 e os 74 anos em bairros desfavorecidos e sobre minorias étnicas — revelando a obesidade não apenas como condição clínica, mas como marcador de desigualdade.
Quando Portugal definiu as prioridades de vacinação, a obesidade ficou de fora da primeira fase. A justificação era pragmática: difícil de verificar em escala, demasiado prevalente — entre 10 a 20% da população — e menos determinante para a mortalidade do que a idade. Uma decisão que refletia, no fundo, a mesma conclusão dos dados portugueses: a obesidade agrava o caminho até ao hospital, mas é a idade que decide quem regressa a casa.
By the spring of 2020, hospital wards across the world began filling with a particular pattern: beds occupied by patients with obesity who had contracted COVID-19 and fallen severely ill. The observation was so consistent that researchers started asking a straightforward question—was obesity itself a risk factor for worse outcomes? The answer, it turned out, was complicated.
A meta-analysis published in August 2020 examined 75 studies spanning nearly 400,000 patients and found that people with obesity faced a 46 percent higher risk of infection with the coronavirus. More striking: if they did contract the virus, their likelihood of requiring hospitalization jumped by 113 percent. The risk of landing in intensive care was 74 percent higher. These numbers, compiled by researchers including Barry Popkin of the University of North Carolina and the World Bank, suggested obesity was a serious vulnerability. After advanced age, it appeared to be the most important risk factor for severe disease.
Portuguese researchers, however, found something unexpected when they examined their own hospital data. Vasco Ricoca Peixoto, working with the Integrated Health Research Center at the National School of Public Health in Lisbon, analyzed records from 16,000 hospitalized COVID-19 patients, including 1,800 admitted to intensive care. His conclusion differed from the international studies: among people already hospitalized, obesity did increase the chances of needing intensive care. But it did not increase the risk of death. Age remained the overwhelming predictor of mortality—patients in their 60s faced three times the death risk, those in their 70s five times, and those 80 and older seven times. Obesity, by itself, did not push that needle further.
The biological mechanisms explaining obesity's role in severe COVID-19 are becoming clearer, even if the full picture remains incomplete. Fat tissue infiltrates organs that produce immune cells, weakening their ability to fight infection. Adipose tissue also releases chemical messengers called cytokines that trigger chronic inflammation—a state that, in COVID-19 patients, can spiral into what researchers call a cytokine storm, where the immune system destroys the body rather than protecting it. Blood in obese patients tends to clot more easily, a dangerous liability given that COVID-19 itself causes cardiovascular complications. Additionally, obese individuals and those with conditions like hypertension and diabetes may have higher concentrations of ACE2 receptors—the cellular locks that the coronavirus uses to enter and hijack human cells.
The question of whether obesity makes people more susceptible to infection in the first place remains unsettled. A New York study of 5,700 hospitalized patients found that 41.7 percent were obese, compared to a citywide obesity rate of 22 percent. But Ricoca Peixoto cautions that such comparisons are laden with confounding variables. Do obese individuals take fewer precautions? Do they socialize differently? Without controlling for exposure and behavior, it is impossible to say whether obesity itself increases infection risk or whether other factors are at play.
The data from Britain's first wave of infections underscored the social dimension of the crisis. Seventy percent of patients admitted to intensive care were obese or overweight. The burden fell heaviest on people aged 55 to 74 living in poor neighborhoods, and on Black, Asian, and other ethnic minority populations—a pattern that revealed obesity not merely as a medical condition but as a marker of inequality and disadvantage.
When Portugal designed its vaccination rollout, obesity did not make the first phase of priority groups. Ricoca Peixoto explained the reasoning: logistically, it would have been difficult to verify obesity status at scale, and age remained the dominant risk factor for both hospitalization and death. More pragmatically, obesity is too common. Estimates suggest 10 to 20 percent of Portugal's population is obese—roughly one million people based on 2014 data. Including such a large swath of the population in the initial vaccination phase would have been impractical and would have diluted the focus on the most vulnerable. The decision reflected a calculation: obesity raises the stakes for hospitalization and strains on health systems, but among those already in hospital beds, it is age, not weight, that determines who survives.
Citações Notáveis
Obesity increases the risk of hospitalization 1.6 times, while age 60-69 increases it two times—making age the more significant factor.— Vasco Ricoca Peixoto, Integrated Health Research Center, National School of Public Health, Lisbon
Among hospitalized COVID-19 patients, obese individuals have higher chances of needing intensive care, but obesity alone does not increase death risk.— Vasco Ricoca Peixoto
A Conversa do Hearth Outra perspectiva sobre a história
Why did international studies show obesity increased death risk when Portuguese hospitals didn't see that?
The difference might be in how you measure. International studies looked at all obese COVID patients, including those who never made it to a hospital bed. Portuguese researchers focused only on people already hospitalized—a group that's already filtered by severity. Once you're sick enough to be admitted, obesity stops being the deciding factor.
So obesity gets you into the hospital, but doesn't kill you there?
Exactly. It's a threshold effect. Obesity pushes you over the line from home care to hospitalization, sometimes to intensive care. But once you're there, receiving treatment, age becomes what matters most for survival.
The article mentions fat tissue releasing inflammatory chemicals. How does that work against the virus?
Your immune system needs to be precise—it should attack the virus without destroying your own organs. In obese patients, that tissue is constantly sending inflammatory signals. When COVID arrives, it's like adding fuel to a fire that's already burning. The immune response becomes chaotic instead of targeted.
Why would obese people have more ACE2 receptors—the locks the virus uses?
We don't fully know. But people with obesity often have hypertension, diabetes, heart disease. Those conditions seem to correlate with higher ACE2 expression. It's as if the virus has more doors to choose from in an obese person's body.
If obesity is so common in Portugal, why not prioritize vaccination for obese people?
Because you can't vaccinate 20 percent of your population in phase one. You'd have no phase one left. And practically speaking, how do you verify it? You'd need to weigh and measure millions of people. Age is visible, documentable, rare enough at the top end to be manageable.
But doesn't that leave vulnerable people unprotected?
It does. But the researchers argued that obesity's real danger is hospitalization and system overload, not death. Age kills. Obesity hospitalizes. Different problems need different solutions.